This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Save the date!
November 6–8, 2023Munich, Germany

Barbara Natke
VP, Business Development at AVEO Oncology


Barbara joined AVEO after serving as Vice President of Business Development at Samyang Biopharm, USA. Prior to Samyang, Dr. Natke served in a variety of roles of increasing responsibility in the Shire/Takeda organization including BD Lead, Scientific Director and Due Diligence Lead. Before making the transition to the business side of the Pharma industry, Barbara spent 8 years running laboratory groups at Genzyme/Sanofi following her post-doctoral studies at the Massachusetts Institute of Technology. Dr. Natke holds a PhD in Biochemistry from Boston University School of Medicine and an MBA from Babson College.

Agenda Sessions

  • Global dealmaking in a global indication: oncology partnering in 2022


Speakers at this event